SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (600196)

RMB 170 Mln Line of Credit Approved

At the 31st Extraordinary Meeting of the 4th Board of Directors, held on 25 Sept 2008, a proposal was examined and approved to apply for a RMB 170 mln line of credit from Bank of Shanghai Co., Ltd., a related party of the company, with a term until 31 Dec 2008 and an interest rate 5% lower than the current benchmark rate.

Shanghai Fosun High-tech (Group) Co., Ltd., the company's controlling shareholder, will provide joint-liability guarantee on the faciilty.

Board of Directors
6 Oct 2008


Source: Shanghai Stock Exchange

Date: 6 Oct 2008

CN01/CJ/JL/BT/MM




Copyright NewsnChina 2010